InsidersTradesSigma
케이엠제약 Stock: price and directors' dealings · South Korea · DART (FSS)
Follow the 케이엠제약 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Banks sector, 케이엠제약 has logged 16 reports. Market capitalisation: €8.5bn. The latest transaction was disclosed on 1 July 2026 (Other). Among the most active insiders: 강일모. Every trade is free.
16
Insider Decl.
0
Thresholds
€72,799
7 ops.
Buy Volume
·
0 ops.
Sell Volume
30Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 24,631 of 25,451 companies
12.8
score / 100
Value7
Quality19
FCF yld-24%
Earn yld-46%
EV/EBITDA·
ROE-13%
Gross mgn24%
Net mgn-25%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 1 July 2026
Declarations16 total
10,000 shares@ ₩519.51590.0000% mcap22.8% of flowShareKRXDART:20260421000222
Ideal exit: 10 Jan 2027 (T+270)
23,111 shares@ ₩650.66570.0001% mcap66.8% of flowShareKRXDART:20260409001498
Ideal exit: 4 Dec 2026 (T+270)
5,994 shares@ ₩390.88740.0000% mcap10.4% of flowShareKRXDART:20260313000274
Ideal exit: 4 Dec 2026 (T+270)
16 of 16 declarations
About 케이엠제약
케이엠제약 is a company in the finance and banking sector, listed on the XKRX exchange.